Company Information

Number of Employees 789

Purdue Pharma and its subsidiaries are physician founded and led the companies to develop manufacture and market medications and consumer health products to meet the evolving needs of healthcare professionals, patients, consumers and caregivers. Products include treatments for chronic and severe pain, including OxyContin, a controlled release version of oxycodone; HysinglaER, an extended-release hydrocodone drug; and buprenorphine pain patch Butrans. The company is committed to driving innovations to address the opioid crisis. Purdue Subsidiary Adlon Therapeutics L. P. focused on treatment for ADHD. The company filed for bankruptcy protection in 2019 after facing extensive scrutiny over its opioid-marketing practices. Through the restructuring, the company will convert into a new public-benefit entity.

NAICS 2017 Code 325412
D-U-N-S® Number 932323652

Contact Information

Contact Name Craig Landau
Title Chief Executive Officer
Address 201 Tresser Blvd, Stamford, CT 06901-3432
Phone 1-203-588-8000

Linked Pathways

Clicking on a link below will provide you with a list of associated and presorted occupations for this current company, by their industry term.